Pharmaceuticals, Biotechnology and Life Sciences
NORTH BRUNSWICK, N.J.–(BUSINESS WIRE)–LinusBio, a leader in precision exposome sequencing, today announced its inclusion in Fierce Medtech’s “Fierce 15” list…
All participants in the Phase 1 pilot study experienced a marked decrease in the burden of infection, and the procedures…
THIO-101 Phase 2 trial nears completion with survival and response data forthcoming; exploration of multiple cancer indications and next-generation molecules…
– Dr. Alley brings 20 years of discovery and drug development experience from the clinical development programs and robust commercial…
– Blood-based diagnostic effectively discriminated between patients who were positive versus negative for amyloid beta on PET scans – –…
DUBLIN–(BUSINESS WIRE)–The “Drug Abuse Testing Market, Size, Global Forecast 2024-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company…
– Over 60 participants dosed in two additional cohorts; initial data expected in the second quarter – – Approximately 50%…
The study represents a potential breakthrough in the treatment of common warts SAN DIEGO–(BUSINESS WIRE)–Nielsen BioSciences, Inc. (“Nielsen”), a privately-held,…
Lantern Pharma will present virtually on Thursday, March 7th at 2 pm Eastern. Lantern’s CEO & President, Mr. Panna Sharma…
Safety and tolerability to be determined at up to 10 study sites in the United States and Canada CAMBRIDGE, Mass.–(BUSINESS…